Abstract:Background: Progressive hearing loss is a common problem in the human population with no effective therapeutics currently available. However, it has a strong genetic contribution, and investigating the genes and regulatory interactions underlying hearing loss offers the possibility of identifying therapeutic candidates. Mutations in regulatory genes are particularly useful for this, and an example is the microRNA miR-96, a post-transcriptional regulator which controls hair cell maturation. Mice and humans carrying mutations in miR-96 all exhibit hearing impairment, in homozygosis if not in heterozygosis, but different mutations result in different physiological, structural and transcriptional phenotypes. Methods: Here we present our characterisation of two lines of mice carrying different human mutations knocked-in to Mir96. We have carried out auditory brainstem response tests to examine their hearing with age and after noise exposure and have used confocal and scanning electron microscopy to examine the ultrastructure of the organ of Corti and hair cell synapses. Bulk RNA-seq was carried out on the organs of Corti of postnatal mice, followed by bioinformatic analyses to identify candidate targets. Results: While mice homozygous for either mutation are profoundly deaf from 2 weeks old, the heterozygous phenotypes differ markedly, with only one mutation resulting in hearing impairment in heterozygosis. Investigations of the structural phenotype showed that one mutation appears to lead to synaptic defects, while the other has a much more severe effect on the hair cell stereociliary bundles. Transcriptome analyses revealed a wide range of misregulated genes in both mutants which were notably dissimilar. We used the transcriptome analyses to investigate candidate therapeutics, and tested one, finding that it delayed the progression of hearing loss in heterozygous mice. Conclusions: Our work adds further support for the importance of the gain of novel targets in microRNA mutants and offers a proof of concept for the identification of pharmacological interventions to maintain hearing.

[Study on Conditional Myosin Light Chain Kinase Gene Knockout Mice Resulting in Hearing Loss].

Myosin Light Chain Kinase Regulates Hearing in Mice by Influencing the F-actin Cytoskeleton of Outer Hair Cells and Cochleae

Knock-In Mice with Myo3a Y137C Mutation Displayed Progressive Hearing Loss and Hair Cell Degeneration in the Inner Ear

Myosin Light-Chain Kinase is Necessary for Membrane Homeostasis in Cochlear Inner Hair Cells.

A mouse model for human hearing loss DFNB30 due to loss of function of myosin IIIA

Deficiency in Na-K-2Cl Co-Transporter Impaired Hearing and Balance in Mice

Phenotypic differences in the inner ears of CBA/CaJ and C57BL/6J mice carrying missense and single base pair deletion mutations in the Cdh23 gene

[Association of Age-Related Hearing Loss with Mice Which Expressed Only One Copy of Gene Encoding NKCC1 Co-Transporter].

Loss of Myh14 Increases Susceptibility to Noise-Induced Hearing Loss in CBA/CaJ Mice

[Mice Lacking of Voltage-Gated L-type Calcium Channel Alpha1d Subunit Have Impaired Sinoatrial Node Function and Caused Deafness].

Deficiency of Klc2 Induces Low-Frequency Sensorineural Hearing Loss in C57BL/6 J Mice and Human

Mouse Screen Reveals Multiple New Genes Underlying Mouse and Human Hearing Loss.

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human mutations

A method for constructing a mouse model of congenital hearing loss by bilateral cochlear ablation

A New Mutation of Sgms1 Causes Gradual Hearing Loss Associated with a Reduced Endocochlear Potential

Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function

Deletion of Kcnj16 in Mice Does Not Alter Auditory Function

Functional and Developmental Changes in the Inner Hair Cell Ribbon Synapses Caused by Myosin VI Knockout and Deafness-Inducing Point Mutation

Deletion of <i>C1ql1</i> Causes Hearing Loss and Abnormal Auditory Nerve Fibers in the Mouse Cochlea

The Role of NKCC1 in Auditory Function of Transgenic Mice Detected by ABR and DPOAE

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human MIR96 mutations